We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
-0.41%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$2.68B
AUM Growth
+$190M
(+7.6%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
8.36%
Top 10 Holdings %
Top 10 Hldgs %
33.25%
Holding
1,438
New
142
Increased
550
Reduced
287
Closed
78
Avg Time Held
3.5
years
Top 10 Avg Time Held
2.8
years
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity Enhanced Mid Cap Core ETF
FMDE
|
+$62.4M |
| 2 |
ALPS O'Shares US Small-Cap Quality Dividend ETF
OUSM
|
+$36.3M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$34.2M |
| 4 |
BlackRock Flexible Income ETF
BINC
|
+$23.1M |
| 5 |
JPMorgan Core Plus Bond ETF
JCPB
|
+$22.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$56.5M |
| 2 |
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$39.3M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$31.8M |
| 4 |
State Street Multi-Asset Real Return ETF
RLY
|
+$13.3M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.19% |
| 2 | Technology | 7.27% |
| 3 | Financials | 5.96% |
| 4 | Healthcare | 3.59% |
| 5 | Industrials | 2.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Salesforce
CRM
$203B
| $5M | 0.19% |
18,613
+986
| +6% | +$307K |
2016 Q4
33 quarters
|
|
102
Boston Scientific
BSX
$64B
| $4.99M | 0.19% |
49,459
+822
| +2% | +$82.8K |
2017 Q4
29 quarters
|
|
103
Schwab US TIPS ETF
SCHP
$16.3B
| $4.97M | 0.19% |
184,933
+111,300
| +151% | +$2.93M |
2022 Q2
11 quarters
|
|
104
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$9.1B
| $4.92M | 0.18% |
152,569
+98,019
| +180% | +$3.29M |
2023 Q3
6 quarters
|
|
105
Enterprise Products Partners
EPD
$76.8B
| $4.85M | 0.18% |
141,980
-3,130
| -2% | -$104K |
2017 Q4
29 quarters
|
|
106
iShares MBS ETF
MBB
$35.9B
| $4.84M | 0.18% |
51,589
-3,271
| -6% | -$303K |
2017 Q3
30 quarters
|
|
107
Bank of America
BAC
$362B
| $4.82M | 0.18% |
115,543
+6,463
| +6% | +$288K |
2017 Q2
31 quarters
|
|
108
Innovator US Equity Power Buffer ETF December
PDEC
$995M
| $4.7M | 0.18% |
125,058
| – | – |
2022 Q4
9 quarters
|
|
109
Capital Group Growth ETF
CGGR
$26.2B
| $4.66M | 0.17% |
136,159
+107,129
| +369% | +$4.01M |
2022 Q3
10 quarters
|
|
110
Coca-Cola
KO
$396B
| $4.59M | 0.17% |
64,144
-13,009
| -17% | -$869K |
2013 Q2
47 quarters
|
|
|
111
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.4B
| $4.59M | 0.17% |
39,720
-88,075
| -69% | -$10.2M |
2020 Q4
17 quarters
|
|
112
Emerson Electric
EMR
$90.4B
| $4.58M | 0.17% |
41,822
+491
| +1% | +$59.2K |
2017 Q3
30 quarters
|
|
113
Energy Transfer Partners
ET
$68.5B
| $4.5M | 0.17% |
242,198
-5,250
| -2% | -$102K |
2018 Q4
25 quarters
|
|
114
Cigna
CI
$79B
| $4.4M | 0.16% |
13,378
+1,007
| +8% | +$303K |
2018 Q4
25 quarters
|
|
115
Walt Disney
DIS
$191B
| $4.37M | 0.16% |
44,227
+956
| +2% | +$103K |
2013 Q2
47 quarters
|
|
116
Accenture
ACN
$138B
| $4.36M | 0.16% |
13,970
+975
| +8% | +$344K |
2013 Q2
47 quarters
|
|
117
Vanguard FTSE Developed Markets ETF
VEA
$228B
| $4.35M | 0.16% |
85,557
+3,385
| +4% | +$171K |
2013 Q2
47 quarters
|
|
118
Lockheed Martin
LMT
$123B
| $4.29M | 0.16% |
9,613
+208
| +2% | +$95.7K |
2017 Q4
29 quarters
|
|
119
Blackrock
BLK
$174B
| $4.25M | 0.16% |
4,489
+328
| +8% | +$321K |
2013 Q2
47 quarters
|
|
120
General Dynamics
GD
$91.2B
| $4.25M | 0.16% |
15,590
+1,389
| +10% | +$361K |
2014 Q1
44 quarters
|
|
121
Uber
UBER
$146B
| $4.24M | 0.16% |
58,253
+57,982
| +21,396% | +$4.18M |
2020 Q3
18 quarters
|
|
122
SS&C Technologies
SSNC
$19.8B
| $4.24M | 0.16% |
50,753
+2,739
| +6% | +$227K |
2019 Q1
24 quarters
|
|
123
Invesco QQQ Trust
QQQ
$487B
| $4.23M | 0.16% |
9,013
+1,030
| +13% | +$523K |
2013 Q2
47 quarters
|
|
124
Charles Schwab
SCHW
$163B
| $4.14M | 0.15% |
52,882
+3,087
| +6% | +$242K |
2019 Q1
24 quarters
|
|
125
Labcorp
LH
$26.4B
| $3.99M | 0.15% |
17,153
+301
| +2% | +$73K |
2016 Q3
34 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q1 2025 Portfolio in Review
As of Q1 2025, Capital Analysts LLC held 1,438 positions worth $2.68B, up 7.6% from $2.49B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Capital Analysts LLC deployed $224M of net new capital in Q1 2025, opening 142 new positions and adding to 550 existing holdings. Its largest new stake was ALPS O'Shares US Small-Cap Quality Dividend ETF: 836,574 shares worth $35.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, up from 67% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $56.5M trimmed.
- Capital Analysts LLC's largest Q1 2025 buy was ALPS O'Shares US Small-Cap Quality Dividend ETF: 836,574 shares worth $35.2M.
- Capital Analysts LLC added most to Fidelity Enhanced Mid Cap Core ETF in Q1 2025, an estimated $62.4M increase.
- Capital Analysts LLC's biggest Q1 2025 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $56.5M.
- Capital Analysts LLC fully exited West Pharmaceutical in Q1 2025, selling an estimated $642K.
- Capital Analysts LLC's ten largest holdings make up 33% of its $2.68B portfolio in Q1 2025.
- Capital Analysts LLC opened 142 new positions and closed 78 in Q1 2025.
- Capital Analysts LLC's portfolio value rose 7.6% quarter-over-quarter to $2.68B.
Based on Capital Analysts LLC's 13F filing for Q1 2025, filed 14 May 2025.